Table 5: Distribution of cases according to the grades of Survivin.
|
Survivin score |
Benign prostatic hyperplasia (%) |
Adenocarcinoma prostate (%) |
|
0 |
1 (6.7) |
0 (0.0) |
|
1 |
2 (13.3) |
0 (0.0) |
|
2 |
5 (33.3) |
0 (0.0) |
|
3 |
1 (6.7) |
0 (0.0) |
|
4 |
3 (20.0) |
0 (0.0) |
|
6 |
3 (20.0) |
8 (53.3) |
|
9 |
0 (0.0) |
7 (46.7) |
|
Total |
15 (100.0) |
15 (100.0) |
P value = 0.002; statistically significant; Chi-square value: 21.27
There is statistically significant difference in the Survivin score between BPH and adenocarcinoma patients.